Regenerative Medicine Going Clinical
August 14, 2012 | Terry Sharrer
Earlier this year, the California Institute for Regenerative Medicine began its new and last strategic plan aimed at shifting resources from basic research to clinical developments. Over the next five years (before the end of its funding in 2017), the institute aims to have ten stem cell therapies in early clinical trials. This piece has the strategic plan as a downloadable document. MORE